oophoroma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. In ovarian cancer after optimal cytoreductive surgery and regular adequate chemotherapy, achieved a clinical complete response, sensitive tumor markers increased again over more than 2 times the upper limit of normal, but imaging examination showed no recurrence of disease; 2. Patients refused to further chemotherapy, surgery and other Western medicine treatment methods; 3. Sign informed consent; 4. Aged 20-75 year old female.
Exclusion criteria
Exclusion criteria: (1) patients with severe hepatorenal insufficiency or severe cardiac dysfunction; (2) patients with severe coagulopathy, skin infections, ulcers and scars are contraindicated; (3) people who have participated in other clinical studies within the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CTCS;ERCC1 expression; | — |
Secondary
| Measure | Time frame |
|---|---|
| Gynecological Sonography;Whole abdominal CT scan and enhanced scan;Senstive tumor markers of ovarian cancer;The ovarian cancer patient quality of life scale FACT-0 (Version 4) score; | — |
Countries
China
Contacts
Guangdong Provical Hospital of Traditional Chinese Medicine